Lotus Eye Hospital Fair Value
Lotus Eye Hospital fair value. Lotus Eye Hospital (LOTUSEYE) average fair value is ₹28.06 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹115.37 (-75.68%), fair value range ₹3.02–₹84.93. For live price and a broader fundamental view, visit LOTUSEYE stock price BSE.
Fair Value Analysis Export
LOTUSEYE Fair Value vs Current Price — Valuation Summary
LOTUSEYE average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Explore LOTUSEYE investment value to estimate fundamental worth using multiple valuation models.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
LOTUSEYE Fair Value Analysis — Data Sources & Coverage
Lotus Eye Hospital financial data sources, valuation methods applied and sector benchmarks used. Check LOTUSEYE market cap trends to track the company's total market size over time.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
LOTUSEYE vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Lotus Eye Hospital P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Apollo Hospitals | APOLLOHOSP | 53.88 | 12.34 | ₹116,947 |
| Broach Lifecare Hospital | BROACH | - | - | ₹9 |
| Dr. Agarwal's Health Care | AGARWALEYE | 86.39 | 7.9 | ₹15,699 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
| Gujarat Kidney and Super… | GKSL | 83.47 | 5.53 | ₹1,434 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.